Dystonia in Parkinson's disease: clinical and pharmacological features.
about
Bromocriptine versus levodopa in early Parkinson's diseaseStriatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystoniaThe genetics of idiopathic torsion dystonia.Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonismPharmacotherapy for advanced Parkinson's disease.Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.Clinical spectrum of levodopa-induced complications.Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?The clinical symptoms of Parkinson's disease.Dystonia in multiple system atrophy.Psychiatric symptoms associated with oculogyric crisis: a review of literature for the characterization of antipsychotic-induced episodes.Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.Drug treatment of Parkinson's diseaseManagement of pain in Parkinson's disease.Neuroradiological covariates of drug-induced parkinsonism and tardive dyskinesia in schizophrenia.Difference of foot posture in two cases of exercise-induced foot dystonia.Motor Complications of Dopaminergic Medications in Parkinson's Disease.Index Finger Pointing (Likely a Subtle Form of Hand Dystonia): Prevalence Across Movement Disorders.
P2860
Q24243591-E06BB756-E39D-408A-B909-CAAD02DC4F6AQ28648007-09A145E2-7303-40E1-A5B1-FE1D33311D8DQ33597960-091A3DB5-54A7-4299-A9DC-375921B31816Q33630384-16BB3557-115F-4061-A5A5-5352132C7911Q33790640-4A4310C7-E59B-4A1A-89D6-AE72F599D586Q33821336-03D91FF5-8C26-4C1B-BCBD-66144DC07DE7Q33863502-61AADF46-0534-492E-B213-F5B3CE82F65AQ34452721-4473F9F7-96C9-4768-A076-CCEEB14E62D9Q34512173-F6117C13-44C1-45E2-8FD7-6C665EFF9585Q34533843-08DF0769-C194-45AD-9A2A-FB63A28C82CFQ35466200-66E85D34-0473-4589-A970-6F8451F5F90FQ36473516-4743AD8A-1555-4842-A82B-9FFE3ABF9153Q36847246-7BCB3D61-09D5-45D1-9012-DAEFD1DFD72FQ36902632-D4B32FDB-9EFA-4F18-BC8B-A6177788426DQ38051280-91D58089-ADE2-4108-AFDE-BB4EF599F3E8Q45098438-E6193840-DB30-4A95-AB78-EA967FD6DFC2Q45759333-0EBABC13-E003-454C-B517-E9FDF6EEE3C6Q55279095-C19E949E-6594-432A-9AF4-14E9748D06F7Q55712409-C79F826C-EEF2-43E7-B6B3-3318C08CA4A7
P2860
Dystonia in Parkinson's disease: clinical and pharmacological features.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Dystonia in Parkinson's disease: clinical and pharmacological features.
@en
Dystonia in Parkinson's disease: clinical and pharmacological features.
@nl
type
label
Dystonia in Parkinson's disease: clinical and pharmacological features.
@en
Dystonia in Parkinson's disease: clinical and pharmacological features.
@nl
prefLabel
Dystonia in Parkinson's disease: clinical and pharmacological features.
@en
Dystonia in Parkinson's disease: clinical and pharmacological features.
@nl
P2860
P356
P1433
P1476
Dystonia in Parkinson's disease: clinical and pharmacological features.
@en
P2093
P2860
P356
10.1002/ANA.410230112
P577
1988-01-01T00:00:00Z